Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Slager

Showing results (151-160 of 277) with videos related to

Pageof 28
Sort By:
American Journal of Human Genetics|January 21, 2003
Mutations in CHEK2 associated with prostate cancer riskXiangyang Dong, Liang Wang, Ken Taniguchi, et al.
Gastroenterology|May 14, 2013
Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older womenN Jewel Samadder, Robert A Vierkant, Lori S Tillmans, et al.
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.
American Journal of Hematology|March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphomaHeather L Gustafson, Song Yao, Bryan H Goldman, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosisBridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
Blood|April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLLSameer A Parikh, Kari G Rabe, Neil E Kay, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJames R Cerhan, Anne Kricker, Ora Paltiel, et al.
The Oncologist|September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic LeukemiaPaul J Hampel, Timothy G Call, Kari G Rabe, et al.
Cancer Causes & Control : CCC|May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
Gut|October 27, 2011
Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older womenDavid Limsui, Robert A Vierkant, Lori S Tillmans, et al.
Pageof 28

Showing results (151-160 of 277) with videos related to

Sort By:
Pageof 28
American Journal of Human Genetics|January 21, 2003
Mutations in CHEK2 associated with prostate cancer riskXiangyang Dong, Liang Wang, Ken Taniguchi, et al.
Gastroenterology|May 14, 2013
Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older womenN Jewel Samadder, Robert A Vierkant, Lori S Tillmans, et al.
Blood Cancer Journal|May 11, 2021
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndromeYucai Wang, Sutapa Sinha, Linda E Wellik, et al.
American Journal of Hematology|March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphomaHeather L Gustafson, Song Yao, Bryan H Goldman, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2013
CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosisBridget Charbonneau, Alice H Wang, Matthew J Maurer, et al.
Blood|April 20, 2021
The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLLSameer A Parikh, Kari G Rabe, Neil E Kay, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectJames R Cerhan, Anne Kricker, Ora Paltiel, et al.
The Oncologist|September 5, 2020
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic LeukemiaPaul J Hampel, Timothy G Call, Kari G Rabe, et al.
Cancer Causes & Control : CCC|May 1, 2012
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphomaJennifer L Kelly, Matthew T Drake, Zachary S Fredericksen, et al.
Gut|October 27, 2011
Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older womenDavid Limsui, Robert A Vierkant, Lori S Tillmans, et al.
Pageof 28